Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q3 2019 · 10-Q
Revenue$81.68M$81.68M+9.0% vs Q3 2018 Net Income$42.76M$42.76M+4.3% vs Q3 2018 EPS Diluted$0.97$0.97±0.0% vs Q3 2018 Operating Income$42,755,000+4.3% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
derived
Margins · derivedOperating margin52.3%−2.4 pt vs Q3 2018
Net margin52.3%−2.4 pt vs Q3 2018
ended Sep 30, 2019 · filed Nov 7, 2019 · 38 d after period end